Compounds > disulfiram
Page last updated: 2024-10-26

disulfiram and Bilirubinemia

disulfiram has been researched along with Bilirubinemia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We aimed to identify potent biliverdin reductase (BVRA) inhibitors as a novel concept for the treatment of severe unconjugated hyperbilirubinemia."7.85Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo. ( Aronson, SJ; Beuers, U; Bosma, PJ; de Waart, DR; Duijst, S; Elferink, RO; Seppen, J; van de Graaf, SF; van Dijk, R, 2017)
"We aimed to identify potent biliverdin reductase (BVRA) inhibitors as a novel concept for the treatment of severe unconjugated hyperbilirubinemia."3.85Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo. ( Aronson, SJ; Beuers, U; Bosma, PJ; de Waart, DR; Duijst, S; Elferink, RO; Seppen, J; van de Graaf, SF; van Dijk, R, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Dijk, R1
Aronson, SJ1
de Waart, DR1
van de Graaf, SF1
Duijst, S1
Seppen, J1
Elferink, RO1
Beuers, U1
Bosma, PJ1

Other Studies

1 other study available for disulfiram and Bilirubinemia

ArticleYear
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo.
    Scientific reports, 2017, 05-10, Volume: 7, Issue:1

    Topics: Acetates; Administration, Oral; Animals; Bilirubin; Cyclopropanes; Disulfiram; Drug Evaluation, Prec

2017